Nov 18 (Reuters) - Cochlear Ltd (COH)
- As patents have expired, trial judgment and court of appeals' decision will not disrupt cochlear's business or customers in united states
- Court of appeals affirmed judgment as to infringement, affirmed judgment as to invalidity of one patent
- Appeal of judgement for scientific research and advanced bionics llc against cochlear ltd and its us subsidiary cochlear americas
- Asx alert-decision in us patent infringement case-coh.ax
- United states court of appeals for federal circuit has entered a decision in appeal of judgment in patent infringement lawsuit by alfred e. Mann foundation
- Court of appeals remanded to district court issue of damages and willfulness of infringement of two claims in one remaining patent at issue
- Court of appeals also reversed judgment of invalidity as to one claim in other patent
- Forums
- ASX - By Stock
- COH
- News: COH Cochlear updates on decision in US patent infringement case
COH
cochlear limited
Add to My Watchlist
0.26%
!
$302.98

News: COH Cochlear updates on decision in US patent infringement case
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$302.98 |
Change
-0.800(0.26%) |
Mkt cap ! $19.80B |
Open | High | Low | Value | Volume |
$303.14 | $304.94 | $300.54 | $8.631M | 28.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 5 | $302.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$303.05 | 60 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 13 | 303.400 |
1 | 3 | 303.390 |
1 | 1 | 303.380 |
6 | 12 | 303.370 |
2 | 6 | 303.360 |
Price($) | Vol. | No. |
---|---|---|
303.440 | 19 | 5 |
303.460 | 13 | 1 |
303.470 | 3 | 1 |
303.490 | 13 | 3 |
303.520 | 13 | 1 |
Last trade - 13.06pm 22/08/2025 (20 minute delay) ? |
Featured News
COH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online